We believe the definition of CCND1 amplification as a unique genomic melanoma subtype, and application of genotype-specific treatments, offers a promising direction for the development of therapeutic strategies for treating melanoma patients with CCND1 amplification. The gene discussed is CCND1; the disease is melanoma.